Tepmetko Tablet
Product Images NDC 44087-5000

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tepmetko (NDC 44087-5000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emd Serono, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tepmetko 01)

FDA Label Image

Principal Display Panel (30 Tablet Blister Pack Carton)

Principal Display Panel (30 Tablet Blister Pack Carton)
TEPMETKĀ® is a type of tablet medication indicated for treating certain medical conditions. The tablets are available in a 225 mg dose per tablet and contain tepotinib as its active ingredient. Each carton containing the tablets is child resistant and consists of three blister cards of ten tablets each, making a total of thirty tablets. This medication is available only with a prescription.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.